Khan, Reas S <br/><br/>
SIRT1 activating compounds reduce oxidative stress mediated neuronal loss in viral induced CNS demyelinating disease.  [electronic resource] 

 -  Acta neuropathologica communications  Jan 2014 
 - 3 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2051-5960 
<br/><br/><label>Standard No.: </label>10.1186/2051-5960-2-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Analysis of Variance<br/>Animals<br/>Carbazoles--therapeutic use<br/>Demyelinating Autoimmune Diseases, CNS--drug therapy<br/>Disease Models, Animal<br/>Dose-Response Relationship, Drug<br/>Female<br/>Hepatitis Viruses--pathogenicity<br/>Hepatitis, Viral, Animal--complications<br/>Mice<br/>Mice, Inbred C57BL<br/>Neurons--pathology<br/>Oxidative Stress--drug effects<br/>Sirtuin 1--antagonists & inhibitors<br/>Stilbamidines<br/>Time Factors